التفاصيل البيبلوغرافية
| العنوان: |
Supplemental parenteral nutrition in critically ill patients: a study protocol for a phase II randomised controlled trial |
| المؤلفون: |
Ridley, Emma, Davies, Andrew, Parke, Rachael, Bailey, Michael, McArthur, Colin, Gillanders, Lyn, Cooper, David, McGuinness, Shay, For the Supplemental Parenteral Nutrition Clinical Investigators |
| بيانات النشر: |
BioMed Central Ltd. |
| سنة النشر: |
2015 |
| المجموعة: |
BioMed Central |
| مصطلحات موضوعية: |
Clinical nutrition, Nutrition therapy, Enteral nutrition, Parenteral nutrition, Critical care, Randomised controlled trials |
| الوصف: |
Background Nutrition is one of the fundamentals of care provided to critically ill adults. The volume of enteral nutrition received, however, is often much less than prescribed due to multiple functional and process issues. To deliver the prescribed volume and correct the energy deficit associated with enteral nutrition alone, parenteral nutrition can be used in combination (termed “supplemental parenteral nutrition”), but benefits of this method have not been firmly established. A multi-centre, randomised, clinical trial is currently underway to determine if prescribed energy requirements can be provided to critically ill patients by using a supplemental parenteral nutrition strategy in the critically ill. Methods/design This prospective, multi-centre, randomised, stratified, parallel-group, controlled, phase II trial aims to determine whether a supplemental parenteral nutrition strategy will reliably and safely increase energy intake when compared to usual care. The study will be conducted for 100 critically ill adults with at least one organ system failure and evidence of insufficient enteral intake from six intensive care units in Australia and New Zealand. Enrolled patients will be allocated to either a supplemental parenteral nutrition strategy for 7 days post randomisation or to usual care with enteral nutrition. The primary outcome will be the average energy amount delivered from nutrition therapy over the first 7 days of the study period. Secondary outcomes include protein delivery for 7 days post randomisation; total energy and protein delivery, antibiotic use and organ failure rates (up to 28 days); duration of ventilation, length of intensive care unit and hospital stay. At both intensive care unit and hospital discharge strength and health-related quality of life assessments will be undertaken. Study participants will be followed up for health-related quality of life, resource utilisation and survival at 90 and 180 days post randomisation (unless death occurs first). Discussion This trial ... |
| نوع الوثيقة: |
report |
| اللغة: |
English |
| العلاقة: |
http://www.trialsjournal.com/content/16/1/587Test |
| الإتاحة: |
http://www.trialsjournal.com/content/16/1/587Test |
| حقوق: |
Copyright 2015 Ridley et al. |
| رقم الانضمام: |
edsbas.545C923E |
| قاعدة البيانات: |
BASE |
